Prostatype Genomics AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 0.055682 million compared to SEK 0.00796 million a year ago. Revenue was SEK 0.055682 million compared to SEK 0.00796 million a year ago. Net loss was SEK 10.08 million compared to SEK 7.39 million a year ago.
For the six months, sales was SEK 0.447369 million compared to SEK 0.26872 million a year ago. Revenue was SEK 0.447369 million compared to SEK 0.26872 million a year ago. Net loss was SEK 17.89 million compared to SEK 12.94 million a year ago.